Thanks Ziploc - I still have a few AMRN shares, still take Vascepa, and urge my friends and anyone who will listen to consider taking it after consulting with their doctor.
Hard to believe how things turned out. I expected a fairer, more rational outcome. I was not fully aware of the Patent Pilot Program and Du's participation in it until fairly recently. I give some links about that in my summary. Hard to believe this would be allowed to happen and go uncorrected in the US. We're in uncharted territory these days.
BTW, the Patent Pilot Program was tried for 10 years and then allowed to expire, about 6 months after the Vascepa case. But, Du, who is now the lead judge in her district, liked the program so she's on record saying she'll continue it in her district despite the program's cancellation nationally.
Giving inexperienced judges extra patent cases for OJT isn't crazy, but a brand new student driver shouldn't be out on the streets without an instructor, and shouldn't start off at the Indy 500 first thing. Her indefensible ruling will probably cost over a million lives over a period of years IMO.
Market Data 
Markets 
AI
